1. Alcelik A, Karacay S, Hakyemez IN, et al. Takayasu arteritis initially mimicking infective endocarditis. Mediterr J Hematol Infect Dis. 2011;3(1):e2011040. DOI:10.4084/MJHID.2011.040.
2. Zhang Y, Yang K, Meng X, et al. Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years. Am J Med Sci. 2018;356(4):357-64. DOI:10.1016/j.amjms.2018.06.021.
3. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075-128. DOI:10.1093/eurheartj/ehv319.
4. Infective endocarditis and infection of intracardiac devices. Clinical guidelines (2021) [cited 2022 Jan 09]. Available from: https://scardio.ru/content/Guidelines/2020/KP_Inf_Endokardit-unlocked.pdf (In Russ.)
5. Espinoza JL, Ai S, Matsumura I. New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory. Pathogens. 2018;7(3):73. DOI:10.3390/pathogens7030073.
6. Watanabe Y, Miyata T, Tanemoto K. Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan: Age and Sex Specificity. Circulation. 2015;132(18):1701-9. DOI:10.1161/CIRCULATIONAHA.114.012547.
7. Goksedef D, Omeroglu SN, Ipek G. Coronary artery and mitral valve surgery in Takayasu's arteritis: a case report. Ann Thorac Cardiovasc Surg. 2012;18(1):68-70. DOI:10.5761/atcs.cr.10.01646.
8. Terao C, Yoshifuji H, Kimura A, et al. Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. Am J Hum Genet. 2013;93(2):289-97. DOI:10.1016/j.ajhg.2013.05.024.
9. Park MC, Lee SW, Park YB, et al. Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005;34(4):284-92. DOI:10.1080/03009740510026526.
10. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA. Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol. 2008;26(3):9-15.
11. Comarmond C, Biard L, Lambert M, et al. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017;136(12):1114-22. DOI:10.1161/CIRCULATIONAHA.116.027094.
12. Ely D, Tan CD, Rodriguez ER, et al. Histological Findings in Infective Endocarditis. Open Forum Infectious Diseases. 2016;3(suppl 1):1111. DOI:10.1093/ofid/ofw172.814.
13. Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19-30. DOI:10.1136/annrheumdis-2019-215672.
14. Halavaara M, Martelius T, Järvinen A, et al. Impact of pre-operative antimicrobial treatment on microbiological findings from endocardial specimens in infective endocarditis. Eur J Clin Microbiol Infect Dis. 2019;38(3):497-503. DOI:10.1007/s10096-018-03451-5.
15. Rovery C, Greub G, Lepidi H, et al. PCR detection of bacteria on cardiac valves of patients with treated bacterial endocarditis. J Clin Microbiol. 2005;43(1):163-7. DOI:10.1128/JCM.43.1.163-167.2005.